ASHLAND, Ky. — UK King’s Daughters is proud to announce the successful completion of the first two Inspire V procedures, marking a significant milestone in the treatment of obstructive sleep apnea in ...

Inspire ® Procedure is the first FDA-approved sleep apnea treatment for children with Down syndrome who are unable to use a CPAP. MemorialCare Miller Children’s & Women’s Hospital Long Beach completed ...

Doctors at ENT Head & Neck Specialists have completed the practice’s 100th Berks County procedure of Inspire — an FDA-approved obstructive sleep apnea treatment option for people who cannot use ...

Earlier this month, Inspire Medical Systems released new clinical outcomes data for its Inspire V system from both a Singapore clinical study and a limited US market launch across ten leading medical ...

Dr. Lauren Jazwick, an otolaryngologist at Columbus Otolaryngology Clinic, has completed the first procedure with the latest generation of Inspire therapy, the Inspire V System at Columbus Community ...

Inspire Medical Systems has performed well in 2023 with its hyperglossal nerve stimulation design for sleep apnea sufferers. The company plans to release a version without a sensor lead in 2024, ...

MINNEAPOLIS, March 15, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and ...

Inspire Medical Systems is a rapidly growing medical technology company specializing in a device that treats Obstructive Sleep Apnea. The company is still in the early stages of developing their ...

for children with Down syndrome who are unable to use CPAP therapy. OSA occurs when the airway collapses during sleep. This prevents the child from taking a good breath while sleeping, leading to a ...